litlas
ログインアカウント作成

Steven D. Nathan

1993–2026 年に発表

160
論文数
21,051
被引用数
74
h 指数
145
i10 指数

被引用数

Steven D. Nathan の年別被引用数1995 年: 被引用 4 件1996 年: 被引用 2 件1997 年: 被引用 3 件1998 年: 被引用 4 件1999 年: 被引用 2 件2000 年: 被引用 1 件2002 年: 被引用 3 件2003 年: 被引用 5 件2004 年: 被引用 3 件2005 年: 被引用 11 件2006 年: 被引用 21 件2007 年: 被引用 39 件2008 年: 被引用 72 件2009 年: 被引用 59 件2010 年: 被引用 58 件2011 年: 被引用 57 件2012 年: 被引用 79 件2013 年: 被引用 92 件2014 年: 被引用 131 件2015 年: 被引用 167 件2016 年: 被引用 165 件2017 年: 被引用 234 件2018 年: 被引用 205 件2019 年: 被引用 689 件2020 年: 被引用 755 件2021 年: 被引用 766 件2022 年: 被引用 825 件2023 年: 被引用 687 件2024 年: 被引用 1,171 件2025 年: 被引用 368 件2026 年: 被引用 24 件2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,845 件、この内訳の 25.1%中国: 引用元論文 629 件、この内訳の 8.6%イギリス: 引用元論文 619 件、この内訳の 8.4%ドイツ: 引用元論文 471 件、この内訳の 6.4%イタリア: 引用元論文 395 件、この内訳の 5.4%フランス: 引用元論文 342 件、この内訳の 4.7%カナダ: 引用元論文 332 件、この内訳の 4.5%オーストラリア: 引用元論文 282 件、この内訳の 3.8%日本: 引用元論文 268 件、この内訳の 3.7%スペイン: 引用元論文 225 件、この内訳の 3.1%オランダ: 引用元論文 196 件、この内訳の 2.7%スイス: 引用元論文 154 件、この内訳の 2.1%
0%25.1%その他 21.5%

機関

分野

  • Medicine90.5%
  • Biochemistry, Genetics and Molecular Biology6.6%
  • Immunology and Microbiology1.1%
  • Engineering0.4%
  • Computer Science0.3%
  • Health Professions0.3%
  • その他0.8%

トピック

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis20.4%
  • Pulmonary Hypertension Research and Treatments7.7%
  • Chronic Obstructive Pulmonary Disease (COPD) Research5.6%
  • Systemic Sclerosis and Related Diseases4%
  • Sarcoidosis and Beryllium Toxicity Research4%
  • Transplantation: Methods and Outcomes3.1%
  • その他55.2%

共著者

全論文

検索で開く
  1. A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

    著者: Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini, Elizabeth A. Fagan, Ian Glaspole, Marilyn K. Glassberg, Eduard Gorina, Peter Hopkins, David Kardatzke, Lisa Lancaster, David J. Lederer, Steven D. Nathan, Carlos A. Pereira, Steven A. Sahn, Robert Sussman, Jeffrey J. Swigris, Paul W. Noble - New England Journal of Medicine 2014 被引用: 3,949

  2. Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

    著者: Aaron B. Waxman, Ricardo Restrepo‐Jaramillo, Thenappan Thenappan, Ashwin Ravichandran, Peter A. Engel, Abubakr Bajwa, Roblee P. Allen, Jeremy Feldman, Rahul Argula, Peter Smith, Kristan Rollins, C. Q. Deng, Leigh Peterson, Heidi Bell, Victor F. Tapson, Steven D. Nathan - New England Journal of Medicine 2021 被引用: 614

  3. Pulmonary hypertension in chronic lung disease and hypoxia

    著者: Steven D. Nathan, Joan Albert Barberà, Seán Gaine, Sergio Harari, Fernando J. Martínez, Horst Olschewski, Karen M. Olsson, Andrew J. Peacock, Joanna Pepke‐Żaba, Steeve Provencher, Norbert Weißmann, Werner Seeger - European Respiratory Journal 2018 被引用: 761

  4. Lactic Acid Is Elevated in Idiopathic Pulmonary Fibrosis and Induces Myofibroblast Differentiation via pH-Dependent Activation of Transforming Growth Factor-β

    著者: R.M. Kottmann, Ajit A. Kulkarni, Katie Smolnycki, Elizabeth Lyda, Thinesh Dahanayake, Rami Salibi, Sylvie Honnons, Carolyn Jones, Nancy Isern, Jian Zhi Hu, Steven D. Nathan, Geraldine M. Grant, Richard P. Phipps, Patricia J. Sime - American Journal of Respiratory and Critical Care Medicine 2012 被引用: 408

  5. Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis

    著者: Lisa Lancaster, João A. de Andrade, Joseph D. Zibrak, María L. Padilla, Carlo Albera, Steven D. Nathan, Marlies Wijsenbeek, John L. Stauffer, Klaus-Uwe Kirchgaessler, Ulrich Costabel - European Respiratory Review 2017 被引用: 288

  6. Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials

    著者: Paul W. Noble, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Roland M. du Bois, Elizabeth A. Fagan, Robert Fishman, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David J. Lederer, Jonathan A. Leff, Steven D. Nathan, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre, Talmadge E. King - European Respiratory Journal 2015 被引用: 463

  7. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis

    著者: Christopher J. Rhodes, Ken Batai, Marta Bleda, Matthias Haimel, Laura Southgate, Marine Germain, Michael W. Pauciulo, Charaka Hadinnapola, Jurjan Aman, Barbara Girerd, Amit Arora, Jo Knight, Ken B. Hanscombe, Jason H. Karnes, Marika Kaakinen, Henning Gall, Anna Ulrich, Lars Harbaum, Inês Cebola, Jorge Ferrer, Katie A. Lutz, Emilia M. Swietlik, Ferhaan Ahmad, Philippe Amouyel, Stephen L. Archer, Rahul Argula, Eric D. Austin, David B. Badesch, Sahil Bakshi, Christopher F. Barnett, Raymond L. Benza, Nitin Bhatt, Harm Jan Bogaard, Charles D. Burger, Murali M. Chakinala, Colin Church, Gerry Coghlan, Robin Condliffe, Paul A. Corris, Cesare Danesino, Stéphanie Debette, C. Gregory Elliott, Jean Elwing, Mélanie Eyries, Terry Fortin, André Franke, Robert P. Frantz, Adaani Frost, Joe G. N. Garcia, Stefano Ghio, Hossein-Ardeschir Ghofrani, J. Simon R. Gibbs, John B. Harley, Hua He, Nicholas S. Hill, Russel Hirsch, Arjan C. Houweling, Luke Howard, D. Dunbar Ivy, David G. Kiely, James R. Klinger, Gábor Kovács, Tim Lahm, Matthias Laudes, Rajiv D. Machado, Robert V. MacKenzie Ross, Keith Marsolo, Lisa J. Martin, Shahin Moledina, David Montani, Steven D. Nathan, Michael Newnham, Andrea Olschewski, Horst Olschewski, Ronald J. Oudiz, Willem H. Ouwehand, Andrew J. Peacock, Joanna Pepke‐Żaba, Zia Ur Rehman, Ivan M. Robbins, Dan M. Roden, Erika B. Rosenzweig, Ghulam Saydain, Laura Scelsi, Robert Schilz, Werner Seeger, Christian M. Shaffer, Robert W. Simms, Marc A. Simon, Olivier Sitbon, Jay Suntharalingam, Haiyang Tang, Alexander Tchourbanov, Thenappan Thenappan, Fernando Torres, Mark Toshner, Carmen Treacy, Anton Vonk Noordegraaf, Quinten Waisfisz, Anna K. Walsworth ほか 18 名 - The Lancet Respiratory Medicine 2018 被引用: 213

  8. Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study

    著者: Steven D. Nathan, Jürgen Behr, Harold R. Collard, Vincent Cottin, Marius M. Hoeper, Fernando J. Martínez, Tamera J. Corte, Anne Keogh, Hanno Leuchte, Nesrin Moğulkoç, Silvia Ulrich, Wim Wuyts, Zhen Yao, Francis Boateng, Athol U. Wells - The Lancet Respiratory Medicine 2019 被引用: 241

  9. Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis

    著者: Christopher J. Lettieri, Steven D. Nathan, Scott D. Barnett, Shahzad Ahmad, Andrew F. Shorr - CHEST Journal 2006 被引用: 871

  10. Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan

    著者: Ganesh Raghu, Juergen Behr, Kevin M. Brown, Jim Egan, Steven M. Kawut, Kevin R. Flaherty, Fernando J. Martínez, Steven D. Nathan, Athol U. Wells, Harold R. Collard, Ulrich Costabel, Luca Richeldi, João A. de Andrade, Nasreen Khalil, Lake Morrison, David J. Lederer, Lixin Shao, Xiaoming Li, Patty Pedersen, A. Bruce Montgomery, Jason W. Chien, Thomas G. O’Riordan, the ARTEMIS-IPF Investigators* - Annals of Internal Medicine 2013 被引用: 543

  11. Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial

    著者: Jürgen Behr, Steven D. Nathan, Wim Wuyts, Nesrin Mogulkoc Bishop, Demosthenes Bouros, Κατερίνα Αντωνίου, Julien Guiot, Mordechai R. Kramer, Klaus-Uwe Kirchgaessler, Monica Bengus, Frank Gilberg, Andras Perjesi, Sergio Harari, Athol U. Wells - The Lancet Respiratory Medicine 2020 被引用: 134

  12. Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management

    著者: Karen M. Olsson, Tamera J. Corte, Jan C. Kamp, David Montani, Steven D. Nathan, Lavinia Neubert, Laura Price, David G. Kiely - The Lancet Respiratory Medicine 2023 被引用: 119

  13. Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosis

    著者: Steven D. Nathan, Carlo Albera, Williamson Z. Bradford, Ulrich Costabel, Ian Glaspole, Marilyn K. Glassberg, David Kardatzke, Monica Daigl, Klaus-Uwe Kirchgaessler, Lisa Lancaster, David J. Lederer, Carlos A. Pereira, Jeffrey J. Swigris, Dominique Valeyre, Paul W. Noble - The Lancet Respiratory Medicine 2016 被引用: 332

  14. Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study

    著者: Steven D. Nathan, Aaron B. Waxman, Sudarshan Rajagopal, Amy Hajari Case, Shilpa Johri, Hilary M. DuBrock, David J. De La Zerda, Sandeep Sahay, Christopher S. King, Lana Melendres‐Groves, Peter Smith, Eric Shen, Lisa Edwards, Andrew C. Nelsen, Victor F. Tapson - The Lancet Respiratory Medicine 2021 被引用: 141

  15. Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation

    著者: Sean Agbor-Enoh, Yan Wang, Ilker Tunc, Moon Kyoo Jang, Andrew A. Davis, Iwijn De Vlaminck, Helen Luikart, Pali D. Shah, I. Timofte, Anne Brown, A. Marishta, K. Bhatti, S. Gorham, U. Fideli, Jennifer Wylie, David R. Grimm, Natalie Goodwin, Yanqin Yang, K. Patel, Jun Zhu, Aldo Iacono, Jonathan B. Orens, Steven D. Nathan, Charles C. Marboe, Gerald J. Berry, Stephen R. Quake, Kiran K. Khush, Hannah A. Valantine - EBioMedicine 2019 被引用: 150

  16. Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study

    著者: Moon Kyoo Jang, Ilker Tunc, Gerald J. Berry, Charles C. Marboe, Hyesik Kong, Michael B. Keller, Pali D. Shah, I. Timofte, Anne Brown, Ileana L. Ponor, Cedric Mutebi, Mary Carmelle Philogene, Kai Yu, Aldo Iacono, Jonathan B. Orens, Steven D. Nathan, Sean Agbor-Enoh - The Journal of Heart and Lung Transplantation 2021 被引用: 92

  17. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury

    著者: T. Andargie, Takayuki Tsuji, Fayaz Seifuddin, Moon Kyoo Jang, Peter S.T. Yuen, Hyesik Kong, Ilker Tunc, Komudi Singh, Ananth Charya, Kenneth J. Wilkins, Steven D. Nathan, Andrea L. Cox, Mehdi Pirooznia, Robert A. Star, Sean Agbor-Enoh - JCI Insight 2021 被引用: 153

  18. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants

    著者: Anna L. Peljto, Rachel Z. Blumhagen, Avram Walts, Jonathan Cardwell, Julia Powers, Tamera J. Corte, Joanne L. Dickinson, Ian Glaspole, Yuben Moodley, Martina Vašáková, Elisabeth Bendstrup, Jesper Rømhild Davidsen, Raphaël Borie, Bruno Crestani, Philippe Dieudé, Francesco Bonella, Ulrich Costabel, Gunnar Guðmundsson, Seamas C. Donnelly, Jim Egan, Michael T. Henry, Michael P. Keane, Marcus P. Kennedy, Cormac McCarthy, Aoife McElroy, Joshua A. Olaniyi, Katherine Ma O’Reilly, Luca Richeldi, Paolo Maria Leone, Venerino Poletti, Francesco Puppo, Sara Tomassetti, Valentina Luzzi, Nurdan Köktürk, Nesrin Moğulkoç, Christine Fiddler, Nikhil Hirani, Gísli Jenkins, Toby M. Maher, Philip L. Molyneaux, Helen Parfrey, Rebecca Braybrooke, Timothy S. Blackwell, Peter Jackson, Steven D. Nathan, Mary K. Porteous, Kevin K. Brown, Jason D. Christie, Harold R. Collard, Oliver Eickelberg, Elena Foster, Kevin F. Gibson, Marilyn K. Glassberg, Daniel J. Kass, Jonathan A. Kropski, David J. Lederer, A. Linderholm, Jim Loyd, Susan Mathai, Sydney B. Montesi, Imre Noth, Justin M. Oldham, Amy Palmisciano, Cristina Reichner, Mauricio Rojas, Jesse Roman, Neil W. Schluger, Barry S. Shea, Jeffrey J. Swigris, Paul J. Wolters, Yingze Zhang, Cecilia M. Prêle, Juan Ignacio Enghelmayer, María Otaola, Christopher J. Ryerson, Mauricio Salinas, Martina Šterclová, Tewodros Haile Gebremariam, Marjukka Myllärniemi, Roberto G. Carbone, Haruhiko Furusawa, Masaki Hirose, Yoshikazu Inoue, Yasunari Miyazaki, Ken Ohta, Shin Ohta, Tsukasa Okamoto, Dong Soon Kim, Annie Pardo, Moisés Selman, Alvaro U. Aranda, Moo Suk Park, Jong Sun Park, Jin Woo Song, María Molina‐Molina, Lurdes Planas‐Cerezales, Gunilla Westergren‐Thorsson, Albert V. Smith, Ani Manichaikul, John S. Kim ほか 15 名 - American Journal of Respiratory and Critical Care Medicine 2023 被引用: 80

  19. Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium

    著者: Steven D. Nathan, Oksana A. Shlobin, Nargues Weir, Shahzad Ahmad, Julienne M. Kaldjob, Edwinia Battle, Michael J. Sheridan, Roland M. du Bois - CHEST Journal 2011 被引用: 365

  20. Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study

    著者: Aaron B. Waxman, Ricardo Restrepo‐Jaramillo, Thenappan Thenappan, Peter A. Engel, ABUBAKR A BAJWA, Ashwin Ravichandran, Jeremy Feldman, Amy Hajari Case, Rahul Argula, Victor F. Tapson, Peter Smith, C. Q. Deng, Eric Shen, Steven D. Nathan - European Respiratory Journal 2023 被引用: 65

  21. Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis

    著者: Steven D. Nathan, Jürgen Behr, Vincent Cottin, Lisa Lancaster, Peter Smith, CQ Deng, Natalie Breytenbach, Heidi Bell, Leigh Peterson, Kevin R. Flaherty - BMJ Open Respiratory Research 2022 被引用: 67

  22. The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD

    著者: Martin Kolb, Stylianos E. Orfanos, Christopher Lambers, Kevin R. Flaherty, Alison Masters, Lisa Lancaster, Adam M. Silverstein, Steven D. Nathan - Advances in Therapy 2022 被引用: 44

  23. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative—Group 3 pulmonary hypertension

    著者: Sylvia Nikkho, Manuel J. Richter, Eric Shen, Steven H. Abman, Katerina Antoniou, Jonathan H. Chung, Peter Fernandes, Paul M. Hassoun, Howard M. Lazarus, Horst Olschewski, Lucilla Piccari, Mitchell A. Psotka, Rajan Saggar, Oksana A. Shlobin, Norman Stockbridge, Patrizio Vitulo, Carmine Dario Vizza, Stephen J. Wort, Steven D. Nathan - Pulmonary Circulation 2022 被引用: 61

  24. A Randomized, Double-Blind, Placebo-Controlled Study of Pulsed, Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis

    著者: Steven D. Nathan, Kevin R. Flaherty, Marilyn K. Glassberg, Ganesh Raghu, Jeffrey J. Swigris, Roger A. Alvarez, Neil Ettinger, Jim Loyd, Peter Fernandes, Hunter Gillies, Bo Kim, Parag S. Shah, Lisa Lancaster - CHEST Journal 2020 被引用: 106